Opinion
Video
Author(s):
Medical experts identify key stakeholders within health plans who collaborate in the decision-making process for coverage, access, and benefit design related to prescription digital therapeutics.
5 Notable FDA Approvals From March Highlight Advancements Across Therapeutic Areas
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Early Adjuvant Immunotherapy Discontinuation Does Not Affect Melanoma Recurrence Risk
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk
EHR-Based Symptom Inventory Shows Potential for Ovarian Cancer Monitoring